Somatrogon for treating growth disturbance in people 3 years and over

NICE

1 February 2023 - Somatrogon is recommended as an option for the treatment of children 3 years of age and over with growth disturbance caused by growth hormone deficiency.

A cost comparison suggests the costs of somatrogon are similar to those of the somatropin preparations.

Read NICE technology appraisal guidance

Michael Wonder

Posted by:

Michael Wonder